Shown: posts 1 to 4 of 4. This is the beginning of the thread.
Posted by bearfan on February 22, 2011, at 17:30:30
Interesting news, Forest Labs bought Clinical Data for over a billion dollars. I'm pretty sure they wouldn't of done this unless they had some inside information about how useful Viibryd was. Lexapro is about to go generic so they need another blockbuster. Also I found an interesting video article with a Doctor that has clinical experience with Viibryd
UPDATE: Forest Labs To Buy Clinical Data For At Least $1.2B
http://online.wsj.com/article/BT-CO-20110222-714059.htmlNew Depression Drug Seems to have fewer side effects; works on Serotonin and Dopamine:
http://www.kens5.com/news/New-depression-drug-seems-to-have-fewer-side-effects-114664759.html
Posted by Phillipa on February 22, 2011, at 18:30:47
In reply to Forest Labs Buys Clinical Data,acquires 'Viibryd', posted by bearfan on February 22, 2011, at 17:30:30
Is this the one with melatonin? Phillipa
Posted by bearfan on February 22, 2011, at 19:21:32
In reply to Re: Forest Labs Buys Clinical Data,acquires 'Viibryd' » bearfan, posted by Phillipa on February 22, 2011, at 18:30:47
No.
Posted by Phillipa on February 22, 2011, at 21:30:05
In reply to Re: Forest Labs Buys Clinical Data,acquires 'Viibryd', posted by bearfan on February 22, 2011, at 19:21:32
Bearfan that's good!!!! Seriously thanks Phillipa
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD, [email protected]
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.